Dr. Wilding is one of the first ophthalmologists in the area to offer the new FDA approved Visian ICL from Staar Surgical.  The Visian ICL is a intraocular lens made of Collamer, STAAR’s proprietary collagen copolymer.  The best candidates for the Visian ICL are between the ages of 21 and 45, with moderate to severe myopia. 

The Visian ICL is capable of correcting a wide range of myopia without the removal or destruction of corneal tissue.  The ICL is a small, foldable, injectable lens that is inserted through a tiny, 3mm incision that does not require suture.  The ICL provides predictable refractive outcomes and excellent quality of vision due to its placement inside the eye, as well as its optical performance.  The ICLs are intended to remain in place without maintenance. 

The ICL surgery is performed on an outpatient basis, which means that the patient has surgery and leaves the same day.  Please note that someone will have to drive the patient to and from surgery.  A light, topical or local anesthetic is administered and there is very little discomfort and normally no pain associated with the procedure.  Some drops or oral medication may be prescribed and a visit is usually scheduled the day after surgery.

This latest option for cataract surgery is available now from Dr. John Wilding at Ohio Vision.  He serves the community in Sidney, St. Marys, Celina and Bellefontaine.  Call Ohio Vision at 937-492-8040 for further information.